Crescent Biopharma, Inc. · NASDAQ:CBIO
Tang Capital Management LLC reported a 5.04% stake in Crescent Biopharma, Inc. (Schedule 13G)
Event Oct 2, 2025 · Filed Oct 9, 2025
Tang Capital Management LLC reported a 5.04% stake in Crescent Biopharma, Inc., 700,000 shares, as a passive investor on Oct 2, 2025. Filed Oct 9, 2025 (Schedule 13G).
- Stake
- 5.04%
- Shares
- 700,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 5.04% | 700,000 |
| KEVIN TANG | 5.04% | 700,000 |
| TANG CAPITAL PARTNERS, LP | 2.84% | 393,681 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.20% | 306,319 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Crescent Biopharma, Inc.
- Tang Capital Management LLC
- Crescent Biopharma, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · May 15, 2026
- Form 4 · Brumm Joshua T · Sep 18, 2026
- Form 4 · McNeill Jonathan · Sep 18, 2026
- Form 4 · Lynch Ryan · Sep 18, 2026
- Form 4 · Pinkas Jan · Sep 18, 2026
- Form 4 · Im Ellie Eunkyung · Sep 18, 2026